Stocks and InvestingStocks and Investing
Tue, April 5, 2022
Mon, April 4, 2022
Sun, April 3, 2022
Fri, April 1, 2022
Thu, March 31, 2022

Brian Abrahams Maintained (ATAI) at Hold with Decreased Target to $9 on, Mar 31st, 2022


Published on 2024-10-27 20:15:26 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Maintained "Atai Life Sciences N.V." (ATAI) at Hold with Decreased Target from $12 to $9 on, Mar 31st, 2022.

Brian has made no other calls on ATAI in the last 4 months.



There is 1 other peer that has a rating on ATAI. Out of the 1 peers that are also analyzing ATAI, 0 agree with Brian's Rating of Hold.



This is the rating of the analyst that currently disagrees with Brian


  • Michael Okunewitch of "Maxim Group" Initiated at Strong Buy and Held Target at $25 on, Tuesday, November 30th, 2021